Autopsy report · NCT00584246

Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome

“Study stopped due to budget (personnel) limitations.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of South Florida

Sponsor type

University, hospital or other

Conditions

Restless Legs Syndrome

Interventions

Pregabalin (Lyrica); Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
  “Study was stopped due to funding and time constraints.” (84% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (80% match in meaning)
• Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
  “Study stopped due to safety reasons.” (78% match in meaning)
• Health Education for Physiotherapy in Soccer Players
  “The study was stopped by insufficient funds” (76% match in meaning)
• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.